OraSure’s Over-The-Counter HIV Test Could Begin Trials This Summer
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies expects to launch clinical studies for an over-the-counter indication for its OraQuick Advance rapid HIV test this summer, according to CEO Douglas Michels
You may also be interested in...
Chembio Joins The Race For Over-The-Counter HIV Test
Chembio Diagnostics intends to join the growing field of companies pursuing over-the-counter indications for their HIV tests now that its products have received FDA approval
Chembio Joins The Race For Over-The-Counter HIV Test
Chembio Diagnostics intends to join the growing field of companies pursuing over-the-counter indications for their HIV tests now that its products have received FDA approval
OraSure Still Hopeful For Government Purchases Of Rapid HIV Tests In 2006
OraSure is concerned but optimistic about future bulk government purchases of its OraQuick Advance test for HIV